Abstract
Within nuclear medicine, theranostics has revitalized the field of targeted radionuclide therapy, and there are a growing number of investigator-initiated and industry-sponsored clinical trials of targeted radionuclide therapy. This article summarizes the current trials available in the National
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Paper Title
Journal
Date
